Zydus receives final approval from USFDA for Topiramate Extended-Release capsules
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
Topiramate Extended-Release capsule had annual sales of US $68.8 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022)
TPE tubing is ideal for pharmaceutical bioprocessing applications because it can be welded to existing tubing lines, and heat-sealed to allow for easy, fast, and safe fluid transport in biopharma processes
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
This product is based on Osmotic Controlled Release Oral Delivery System technology
Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
40,000 visitors and representatives of more than 80 countries set to visit the show
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
Subscribe To Our Newsletter & Stay Updated